Pfizer’s Experimental Drug Works in Ulcerative Colitis

Pfizer Inc.’s experimental rheumatoid arthritis pill tofacitinib eased symptoms of patients with ulcerative colitis, an inflammatory bowel disease that affects 750,000 Americans, a company-sponsored study showed.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.